References
- Maurer HR . Bromelain: biochemistry, pharmacology and medical use. Cell. Mol. Life Sci.58(9), 1234–1245 (2001).
- Ramli AN , AznanTN , IlliasRM. Bromelain: from production to commercialisation. J. Sci. Food Agric.97(5), 1386–1395 (2017).
- Fitzhugh DJ , ShanS , DewhirstMW , HaleLP. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin. Immunol.128(1), 66–74 (2008).
- Huang JR , WuCC , HouRC , JengKC. Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14. Immunol. Invest.37(4), 263–277 (2008).
- Secor ER , SinghAJr , GuernseyLAet al. Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro. Int. Immunopharmacol.9(3), 340–346 (2009).
- Kalra N , BhuiK , RoyPet al. Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol. Appl. Pharmacol.226(1), 30–37 (2008).
- Bhui K , PrasadS , GeorgeJ , ShuklaY. Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett.282(2), 167–176 (2009).
- Bhui K , TyagiS , SrivastavaAKet al. Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)/M arrest to apoptosis. Mol. Carcinog.51(3), 231–243 (2012).
- Walker AF , BundyR , HicksSM , MiddletonRW. Bromelain reduces mild acute knee pain and improves well being in a dose dependant fashion in an open study of otherwise healthy adults. Phytomedicine9, 681–686 (2002).
- Secor ER , CarsonWF , SinghAet al. Oral bromelain attenuates inflammation in an ovalbumin-induced murine model of asthma. Evid. Based. Complement. Alternat. Med.5(1), 61–69 (2008).
- Braun JM , SchneiderB , BeuthHJ. Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany. In Vivo19(2), 417–421 (2005).
- Secor ER Jr , CarsonWF4th , CloutierMMet al. Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease. Cell. Immunol.237(1), 68–75 (2005).
- Juhasz B , ThirunavukkarasuM , PantRet al. Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium. Am. J. Physiol. Heart Circ. Physiol.294(3), H1365–H1370 (2008).
- Stenton SB , BungardTJ , AckmanML. Interactions between warfarin and herbal products, minerals and vitamins: a pharmacist's guide. Can. J. Hosp. Pharm.54, 184–190 (2001).
- Hale LP , GreerPK , TrinhCT , GottfriedMR. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin. Immunol.116(2), 135–142 (2005).
- Onken JE , GreerPK , CalingaertB , HaleLP. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin. Immunol.126(3), 345–352 (2008).
- Mynott TL , GuandaliniS , RaimondiF , FasanoA. Bromelain prevents secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro. Gastroenterology113(1), 175–184 (1997).
- Pellicano R , StronaS , SimondiDet al. Benefit of dietary integrators for treating functional dyspepsia: a prospective pilot study. Minerva Gastroenterol. Dietol.55(3), 227–235 (2009).
- Barth H , GuseoA , KleinR. In vitro study on the immunological effect of bromelain and trypsin on mononuclear cells from humans. Eur. J. Med. Res.10(8), 325–331 (2005).
- Pavan R , JainS , ShraddhaKumar A. Properties and therapeutic application of bromelain: a review. Biotechnol. Res. Int.2012, 976203 (2012).
- Brien S , LewithG , WalkerA , HicksSM , MiddletonD. Bromelain as a treatment for osteoarthritis: a review of clinical studies. evid. based complement. Alternat. Med.1(3), 251–257 (2004).
- Kaur DR , AbmwaniDS , MehtaB. Trypsin, rutoside and bromelain alone and fixed dose combination: a natural, safer and effective anti-inflammatory agent. J. Drug Deliv. Therapeut.4, 108–110 (2014).
- Hoeger PH , NiggemannB , GanschowR , DammannC , HaeuserG. Serum levels of sCD23 and sCD25 in children with asthma and in healthy controls. Allergy49(4), 217–221 (1994).
- Sharma SP , BrajbhushanB. A study on nutritional efficacy of pineapple juice in the treatment of bronchial asthma. Int. J. Sci. Res. Publ.5(1), 1–4 (2015).
- Paulson SK , VaughnMB , JessenSMet al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J. Pharmacol. Exp. Ther.297(2), 638–645 (2001).
- Tang C , ShouM , MeiQ , RushmoreTH , RodriguesAD. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor. J. Pharmacol. Exp. Ther.293, 453–459 (2000).
- Werner U , WernerD , RauT , FrommMF , HinzB , BruneK. Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans. Clin. Pharmacol. Ther.74, 130–137 (2003).
- Harmanci K , BakirtasA , TurktasI , DegimT. Oral montelukast treatment of preschool-aged children with acute asthma. Ann. Allergy Asthma Immunol.96(5), 731–735 (2006).
- Cheng H , LeffJA , AminRet al. Pharmacokinetics, bioavailability and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm. Res.13(3), 445–448 (1996).
- Chiba M , XuX , NishimeJA , BalaniSK , LinJH. Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans. Drug Metab. Dispos.25(9), 1022–1031 (1997).
- Karonen T , NeuvonenPJ , BackmanJT. CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast. Br. J. Clin. Pharmacol.73(2), 257–267 (2012).
- Mougey EB , FengH , CastroM , IrvinCG , LimaJJ. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response.Pharmacogenet. Genomics19(2), 129–138 (2009).
- Kamath AV , YaoM , ZhangY , ChongS. Effect of fruit juices on the oral bioavailability of fexofenadine in rats. J. Pharm. Sci.94(2), 233–239 (2005).
- Hidaka M , NagataM , KawanoYet al. Inhibitory effects of fruit juices on cytochrome P450 2C9 activity in vitro. Biosci. Biotechnol. Biochem.72(2), 406–411 (2008).
- Rodríguez-Fragoso L , Martínez-ArismendiJL , Orozco-BustosD , Reyes-EsparzaJ , TorresE , BurchielSW. Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters. J. Food Sci.76(4), R112–R124 (2011).
- Mougey EB , LangJE , WenX , LimaJJ. Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast. J. Clin. Pharmacol.51(5), 751–760 (2011).
- Cingi C , TorosSZ , GürbüzMKet al. Effect of grapefruit juice on bioavailability of montelukast. Laryngoscope123(4), 816–819 (2013).
- Mallhi TH , SarriffA , AdnanASet al. Effect of fruit/vegetable-drug interactions on CYP450, OATP and p-glycoprotein: a systematic review. Trop. J. Pharm. Res.14(10), 1927–1935 (2015).
- Hanley MJ , CancalonP , WidmerWW , GreenblattDJ. The effect of grapefruit juice on drug disposition. Expert Opin. Drug Metab. Toxicol.7(3), 267–286 (2011).
- Bromelain Monograph . Alternative Medicine Review.15(4), 361–368 (2010). http://chiro.org/alt_med_abstracts/ABSTRACTS/Bromelain_Monograph.pdf
- Abdul majid FA , TheLC , YapLF , AbdulGani M , MashudinM , ShiewPS. Pineapple is a super fruit, but how much can it be consumed?Acta. Horticulturae doi:10.17660/ActaHortic.2016.1111.30 (2016).
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use . ICH harmonised tripartite guideline: guideline for good clinical practice. (2018). https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2F/Step4/E2F_Step_4.pdf
- Helmy SA , El-BedaiwyHM. Validation of a liquid chromatography method for the simultaneous determination of several nonsteroidal anti-inflammatory drugs in human plasma for therapeutic drug monitoring. Ther. Drug Monit.36(1), 100–107 (2014).
- Alsarra IA . Development of a stability-indicating HPLC method for the Determination of montelukast in tablets and human plasma and its applications to pharmacokinetic and stability studies. Saudi Pharm. J.12(4), 136–143 (2004).
- Hedaya MA . Basic Pharmacokinetics.Taylor & Francis, FL, USA (2007).
- SAS Institute Inc . SAS/STAT User's Guide, Version 6 (4th Edition), (Vol. 2).SAS Institute, NC, USA (1990).
- Westlake WF . Use of confidence interval in analysis of comparative bioavailability trials. J. Pharm. Sci.61, 1340–1341 (1972).
- Bala M , IsmailNA , MelM , JamiMS , SallehHM , AmidA. Bromelain production: current trends and perspective. Arch. Des. Sci.65(11), 369–399 (2012).
- Hossain F , AkhtarS , AnwarM. Nutritional value and medicinal benefits of pineapple. Int. J. Nut. Food Sci.4(1), 84–88 (2015).
- Bodi T . The effects of oral bromelains on tissue permeability to antibiotics and pain responseto bradykinin: double blind studies on human subjects. Clin. Med.73, 61–65 (1966).
- Kumakura S , YamashitaM , TsurufujiS. Effect of bromelain on kaolin-induced inflammation in rats. Eur. J. Pharm.150(3), 295–301 (1988).
- Gaspani L , LimiroliE , FerrarioP , BianchiM. In vivo and in vitro effects of bromelain on PGE(2) and SP concentrations in the inflammatory exudate in rats. Pharmacology65(2), 83–86 (2002).
- Majeed M , BoroleK. Evaluation of anti-inflammatory effect of pineapple juice in rheumatoid and osteoarthritis models in rats. Ind. J. Pharmacol.45, S23–S23 (2013).
- Inoue K , MotonagaA , NishimuraTet al. Mechanism of anti-inflammatory action of etodolac. Arzneimittelforschung41(3), 235–239 (1991).
- Klein G , KullichW. Reducing pain by oral enzyme therapy in rheumatic diseases. Wien. Med. Wochenschr.149(21–22), 577–580 (1999).
- Akhtar NM , NaseerR , FarooqiAZ , AzizW , NazirM. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study. Clin. Rheumatol.23(5), 410–415 (2004).
- Taub SJ . The use of ananase in sinusitis: a study of 60 patients. Eye Ear Nose Throat Mon.45(6), 96 (1966).
- Seltzer AP . Adjunctive use of bromelains in sinusitis: a controlled study. Eye Ear Nose Throat Mon.46(10), 1281–1288 (1967).
- Ryan RE . A double-blind clinical evaluation of bromelains in the treatment of acute sinusitis. Headache7(1), 13–17 (1967).
- Muñoz E , OcampoD , EspinalE , YépesN. Bioequivalence study of two 10 mg montelukast immediate-releasetablets formulations: a randomized, single-dose, open-label, two periods, crossover study. Bioequiv. Availab.6(3), 086–090 (2014).
- Shono Y , JantratidE , JanssenNet al. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling. Eur. J. Pharm. Biopharm.73(1), 107–114 (2009).
- Niemi M , PasanenMK , NeuvonenPJ. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol. Rev.63(1), 157–181 (2011).
- Gayasuddin M , KavimaniS , ShakilSait S , VenkataiahG , ParvezM. Effect of Ananas comosus L. juice on the efficacy of glimepiride in alloxan induced diabetic rats. Der Pharmacia Lettre.5(1), 323–326 (2013).
- Chatuphonprasert W , JarukamjornK. Impact of six fruits--banana, guava, mangosteen, pineapple, ripe mango and ripe papaya--on murine hepatic cytochrome P450 activities. J. Appl. Toxicol.32(12), 994–1001 (2012).
- Lan T , RaoA , HaywoodJet al. Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides. Drug Metab. Dispos.37(12), 2375–2382 (2009).
- Amadi C , BarileelaL. Effect of pineapple (ananas comosus) and uziza (piper guineense) extracts on fexofenadine bioavailability: possible role of p-glycoprotein (P-GP) and organic anion transporting polypeptides (OATPs). Int. Res. J. Pharm.9(3), 17–21 (2018).
- Balani SK , XuX , PrathaVet al. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. Drug Metab. Dispos.25, 1282–1287 (1997).
- Cardoso Jde O , OliveiraRV , LuJB , DestaZ. Invitro metabolism of montelukast by cytochrome P450s and UDP-glucuronosyltransferases. Drug Metab. Dispos.43(12), 1905–1916 (2015).
- Kahlon TS , SmithGE. In vitro binding of bile acids by bananas, peaches, pineapple, grapes, pears, apricots and nectarines. Food Chem.101, 1046–1051 (2007).
- Gerber W , SteynJD , KotzéAF , HammanJH. Beneficial pharmacokinetic drug interactions: a tool to improve the bioavailability of poorly permeable drugs. Pharmaceutics10(3), 106 (2018).
- Li X , HuJ , WangBet al. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb–drug interactions mediated via P-gp. Toxicol. Appl. Pharmacol.275(2), 163–175 (2014).